Home › WISeR Prior-Authorization Model
Prior authorization Traditional Medicare only 6 live statesCMS WISeR Model: What Independent Specialty Practices Need to Know About New Prior-Auth Requirements
If your practice is in Texas, New Jersey, Ohio, Oklahoma, Arizona, or Washington and you treat Traditional Medicare patients, a new CMS prior-authorization model is directly affecting your claims. Here is what it is, which procedures it covers, and how Apex Flow's denial-intelligence engine maps those denials to the payer's own policy to surface what is actually recoverable.
What WISeR is
The Wasteful and Inappropriate Service Reduction (WISeR) Model is a CMS innovation model that requires prior authorization for specific procedures billed to Traditional (Original) Medicare. Its stated goal is to reduce spending on services CMS has identified as potentially wasteful or overutilized. The model runs from January 2026 through December 2031.
WISeR is not a coverage policy — it does not eliminate a procedure's coverage. It adds a mandatory prior-authorization step before payment. A missing or denied authorization translates directly into a claim denial, which is why practices in the six live states are seeing new CARC 197 (prior authorization absent) denials on procedure families they have billed without issue for years.
The 6 live WISeR states
WISeR currently operates in these six states:
Practices located in any of these states that bill Traditional Medicare for WISeR-targeted procedures must obtain prior authorization through the MAC before the date of service.
Which procedures WISeR covers
CMS publishes the full procedure list in Appendix A of the WISeR Operational Guide. The major families relevant to independent specialty practices are:
- Spinal injections and surgery — interlaminar and transforaminal epidural steroid injections (ESIs), vertebroplasty, kyphoplasty, and select cervical fusion codes. Pain management and orthopedic practices carry the heaviest exposure here.
- Nerve stimulators — spinal cord stimulator implants (open/paddle electrode), vagus nerve stimulators, phrenic nerve stimulators, and hypoglossal nerve stimulation for sleep apnea. Neurology and pain management are the primary specialties affected.
- Knee arthroscopy — surgical debridement and chondroplasty for osteoarthritis. Orthopedic practices should confirm authorization before every qualifying case.
- Urinary-incontinence devices — male and female sling procedures, inflatable sphincters, and sacral nerve stimulators (when billed with the generator code).
- Penile prostheses — all insertion codes (inflatable and semi-rigid).
- Skin and tissue substitutes — this family requires prior authorization in TX, NJ, OH, and OK. It was withdrawn from WISeR in AZ and WA (Noridian/JF jurisdiction) per CMS Operational Guide v6.0. Practices in AZ or WA should NOT be receiving WISeR-specific PA denials on skin substitute codes.
This is not a complete reproduction of Appendix A — CMS controls the definitive list. Always verify the current version before assuming a code is or is not subject to WISeR.
Why practices are seeing more prior-auth denials
WISeR went live in January 2026. Practices that had not obtained prior authorization for covered procedures before the service date are seeing denials under CARC 197 (prior authorization absent) — and, where an approved authorization's limits are exceeded, CARC 198 (authorization number exceeded). The volume is concentrated in pain management, orthopedics, and neurology because the spinal and nerve-stimulator procedure families carry the highest WISeR exposure.
There are two distinct denial types to separate:
- Pre-service denials — the MAC denied or pended the authorization request. These require a medical-necessity appeal backed by the payer's own coverage criteria before the claim can be resubmitted.
- Post-service denials — the claim was submitted without authorization (or with an expired one). Some MACs permit retroactive authorization requests with documented clinical urgency; others do not. The path forward depends on the MAC and the specific procedure.
KFF research found that roughly 80% of appealed prior-authorization denials across payers are eventually overturned — but only about 1 in 9 are ever appealed (KFF). That gap is where recoverable revenue disappears.
How Apex Flow's engine approaches WISeR denials
Apex Flow is not a billing company. We built a forensic denial-intelligence engine — software that analyzes every denial by CARC code, maps it to the payer's own published coverage policy, and diagnoses what actually happened and what is recoverable. WISeR is a defined module inside that engine.
For WISeR-specific denials, the engine does three things:
- Flags exposure by procedure family and state. The engine cross-references each claim's procedure code against the full CMS Appendix A code list and the client's MAC jurisdiction — including the skin-substitute carve-out for AZ and WA. It distinguishes Traditional Medicare from Medicare Advantage so WISeR denials are not mixed with MA prior-auth denials, which follow completely different appeal rules.
- Maps to the governing coverage policy. A WISeR prior-auth denial is only appealable if the procedure meets the MAC's coverage criteria. The engine pulls the relevant LCD or NCD and maps the clinical record to those criteria — so every appeal is built on the payer's own rules, not a generic argument.
- Surfaces what is and is not recoverable. Not every WISeR denial is the same. Some are correctable via retroactive authorization; some require a full medical-necessity appeal through the Medicare redetermination pathway; some are write-offs if the service genuinely did not meet criteria. The engine categorizes each claim, gives it a recovery pathway, and flags what needs analyst review — never forcing a classification when the facts are ambiguous.
The free engine audit runs on your actual claims — not a sample, not a generic benchmark. You see, on your own data, which WISeR-related denials are in your A/R, which pathways apply, and what the recoverable pool looks like. That is the proof. Recovery on contingency — $0 setup, you pay only on what we collect.
WISeR — FAQ
Does WISeR apply to Medicare Advantage plans?
No. The CMS WISeR Model applies to Traditional (Original) Medicare only — not Medicare Advantage (Part C) plans. Medicare Advantage plans operate under their own prior-authorization rules set by each plan. If your payer name includes "Advantage," "Complete," "HMO," or "PPO," it is likely an MA product and falls outside WISeR.
What procedures require prior authorization under WISeR?
WISeR covers several procedure families for Traditional Medicare in the six live states: spinal injections and select fusions, vertebral augmentation, select nerve stimulators, knee arthroscopy for osteoarthritis, urinary-incontinence devices, penile prostheses, hypoglossal nerve stimulation for sleep apnea, and skin/tissue substitutes (TX, NJ, OH, OK only — withdrawn for AZ and WA). The authoritative list is CMS Appendix A of the WISeR Operational Guide.
Can a WISeR prior-authorization denial be appealed?
Yes. A prior-auth denial under WISeR follows the standard Medicare appeal pathway: Redetermination, Reconsideration (QIC), ALJ hearing, Medicare Appeals Council, and federal district court if needed. The key is matching the clinical documentation precisely to the MAC's coverage criteria (LCD/NCD) before filing. KFF research found roughly 80% of appealed prior-authorization denials are eventually overturned — but only about 1 in 9 denials are ever appealed (KFF). No outcome can be promised, but the documentation match is what determines whether an appeal has merit.